Ugur Sahin
Co-Founder and CEO
Management
BioNTech
Germany
Biography
Ugur Sahin is the co-founder and CEO of BioNTech AG. His key focus is translating scientific ideas into innovations that help individual patients, an interest that was originally prompted by his experiences as a trained physician. Ugur has received prestigious awards from the German Hemato-Oncology Association, the German Association for Immunology, the German Ministry of Education and Research, and the American Society of Clinical Oncology. Ugur is a co-founder of Ganymed Pharmaceuticals, a co-founder and chair of the translational research institute TRON, and a co-founder of the CI3- Rhein-Main Cluster for Individualized Immune Intervention.
Research Interest
Oncology, Immunology
